Paracetamol as Antipyretic and Analgesic Medication

• Status: Completed
• Trial end date: 2010-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The present study is aiming to unravel the clinical efficacy of intravenously administered paracetamol as antipyretic and analgesic medication in various medical conditions.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Athens
• Treatments: Acetaminophen; Analgesics; Antipyretics

Criteria

Inclusion Criteria:

• Age greater than or equal to 18 years

• Written informed consent by the patients

• Medical condition necessitating the administration of antipyretic or analgesic medications

Exclusion Criteria:

• Αge lower than 18 years

• Lack of informed consent

• History of liver cirrhosis

• Blood creatinine greater than 3mg/dl

• Blood AST greater than 3 times the upper normal level according to the lab of the participating hospital

• History of hypersensitivity to non-steroidal ant-inflammatory drugs

• History of abuse of analgesics

• Pregnancy or lactation

• Fulminant hemorrhage of the upper or lower digestive tract

• Thrombocytopenia defined as less than 50000 platelets/μl